Approval · Notice of Compliance 12130 · 2011
AVA-RANITIDINE: Notice of Compliance 12130
Issued March 4, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12130
- Date
- March 4, 2011
- Company
- Avanstra IncCalgary, Alberta, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Histamine H2-receptor antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AVA-RANITIDINE | 02363526 | — |
Medicinal ingredients
- RANITIDINE HCL 15 MG per ML